151 related articles for article (PubMed ID: 9529409)
1. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.
Lindberg G; Bingefors K; Ranstam J; Råstam L; Melander A
BMJ; 1998 Mar; 316(7133):741-5. PubMed ID: 9529409
[TBL] [Abstract][Full Text] [Related]
2. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
Sørensen HT; Mellemkjaer L; Olsen JH
Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
[TBL] [Abstract][Full Text] [Related]
3. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
4. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
[TBL] [Abstract][Full Text] [Related]
5. Calcium-channel blockers and risk of cancer.
Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular drugs and the risk of suicide: a nested case-control study.
Callréus T; Agerskov Andersen U; Hallas J; Andersen M
Eur J Clin Pharmacol; 2007 Jun; 63(6):591-6. PubMed ID: 17468865
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
8. Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression.
Dunn NR; Freemantle SN; Mann RD
Br J Clin Pharmacol; 1999 Aug; 48(2):230-3. PubMed ID: 10417501
[TBL] [Abstract][Full Text] [Related]
9. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
10. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
11. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
12. The risk of myocardial infarction associated with antihypertensive drug therapies.
Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW
JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
14. Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
Hager WD; Davis BR; Riba A; Moye LA; Wun CC; Rouleau JL; Lamas GA; Pfeffer MA
Am Heart J; 1998 Mar; 135(3):406-13. PubMed ID: 9506325
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.
Bokrantz T; Schiöler L; Boström KB; Kahan T; Mellström D; Ljungman C; Hjerpe P; Hasselström J; Manhem K
J Hypertens; 2020 Jan; 38(1):167-175. PubMed ID: 31568060
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
[TBL] [Abstract][Full Text] [Related]
19. Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale.
Verdecchia P; Schillaci G; Reboldi G; Borgioni C; Ciucci A; Porcellati C
Diabetes Nutr Metab; 1999 Aug; 12(4):292-9. PubMed ID: 10782756
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive drugs and the risk of idiopathic aplastic anaemia.
Myers MW; Vasilakis C; Kaufman MR; Jick H
Br J Clin Pharmacol; 2000 Jun; 49(6):604-8. PubMed ID: 10848725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
